POTOMAC, MD / ACCESSWIRE / January 8, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ('IGC Pharma' or the 'Company') announced today that its ongoing Phase 2 trial for agitation in Alzheimer's disease ...

China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.

The industry’s intellectual property manipulations are stealing from your pockets—and limiting the benefits of the Biden ...

The obesity market was a dominating force in 2024, with GLP-1 medications from Novo Nordisk and Eli Lilly becoming some of ...

Here are some clinical trials that could send Big Pharma shares soaring, or crashing, in 2025. Eli Lilly. The world’s biggest ...

Research projects that generative AI could boost the pharma and medical-product industries' annual revenues by up to $110 ...

INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to ...

The "Strategic Intelligence: Big Data in Pharma" report has been added to ResearchAndMarkets.com's offering. A dedicated report examining the pivotal healthcare, technological, macroeconomic, and ...

Big Pharma has many excuses to defend its abuse ... patent is filed to when the drug goes through all the necessary clinical trials and makes it to market. By the time the first dose is sold ...

The AI in cancer care market is set to grow from $2.2 billion in 2024 to $6.3 billion by 2029, driven by advancements in drug ...

Full mergers and acquisitions in the pharmaceutical and biotechnology in 2024 fluctuated throughout the year with hardly any in some months and a significant number in other. But one thing was clear – ...